ArticleCVIR endovascular2026

The ups and downs of paclitaxel-coated balloons and paclitaxel eluting stents: do the conclusions of SWEDEPAD 2 change our practice? Should we be concerned about mortality (again)?

Stefan Müller-Hülsbeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.